Get the Stockscreener App
11.70
2.58%
-0.31
Bannix Acquisition Corp stock is traded at $11.70, with a volume of 1,735.
It is down -2.58% in the last 24 hours and up +4.44% over the past month.
Bannix Acquisition Corp is a blank check company.
See More
Previous Close:
$12.01
Open:
$12.45
24h Volume:
1,735
Relative Volume:
0.36
Market Cap:
$33.33M
Revenue:
-
Net Income/Loss:
$65,400
P/E Ratio:
-780.00
EPS:
-0.015
Net Cash Flow:
$-1.12M
1W Performance:
+2.63%
1M Performance:
+4.44%
6M Performance:
+6.46%
1Y Performance:
+8.33%
1-Day Range:
$11.70
$12.45
1-Week Range:
$11.40
$12.74
52-Week Range:
$10.81
$12.74
Bannix Acquisition Corp Stock (BNIX) Company Profile
Name
Bannix Acquisition Corp
Sector
Industry
Phone
(201) 712-9800
Address
300 TICE BLVD, WOODCLIFF LAKE
Compare BNIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNIX
Bannix Acquisition Corp
|
11.70 | 33.33M | 0 | 65,400 | -1.12M | -0.015 |
|
LION
Lionsgate Studios Corp
|
6.92 | 2.00B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
BZAI
Blaize Holdings Inc
|
7.56 | 792.89M | 0 | 0 | 0 | 0.00 |
|
AACT
Ares Acquisition Corporation Ii
|
11.00 | 687.50M | 0 | 16.92M | -1.35M | 0.29 |
|
ANNA
Aleanna Inc
|
11.50 | 466.44M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.51 | 453.24M | 0 | 1.30M | 0 | 0.0301 |
Bannix Acquisition Corp Stock (BNIX) Latest News
BNIX stock soars to all-time high of $11.8 amid robust growth - MSN
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination - citybiz
Bannix Acquisition Corp. Extends Business Combination Deadline - TipRanks
Bannix Acquisition Corp defers $2.95M in costs - Investing.com India
Bannix Acquisition Corp defers $2.95M in costs By Investing.com - Investing.com Australia
CNH announces Global Leadership Team changes - The Manila Times
Bannix Acquisition Corp. Extends Initial Business Combination Deadline to January 14, 2025 - Nasdaq
Bannix Acquisition Corp Extends SPAC Deadline Again in Search for Merger Target - StockTitan
Bannix Acquisition Corp. faces Nasdaq delisting notice - Investing.com India
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors - The Manila Times
Bannix Acquisition Corp. Extends Deadline for Business Merger - TipRanks
BNIXBannix Acquisition Corp. Latest Stock News & Market Updates - StockTitan
Bannix Acquisition Corp. Extends Business Combination Deadline to December 2024 | BNIX Stock News - StockTitan
Bannix Acquisition Corp. (BNIX) Quarterly 10-Q Report - Quartzy
Long Term Trading Analysis for (BNIX) - Stock Traders Daily
How to Trade US Stocks in Singapore Right Now - Benzinga
(BNIX) Trading Advice - Stock Traders Daily
Arcology introduces Ethereum's first parallel execution rollup - The Manila Times
Bannix Acquisition Corp. Extends Merger Deadline to 2024 - TipRanks
(BNIX) Investment Report - Stock Traders Daily
BP share price weakness is presenting a golden opportunity for long-term investors - Yahoo Finance UK
(BNIX) Trading Signals - Stock Traders Daily
Canopy Growth Announces Results of Annual General Meeting - Yahoo Canada Finance
How Many Stocks Are There in 2024? - Benzinga
James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World
BANX stock touches 52-week high at $20.8 amid robust growth - Investing.com Canada
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Positive Ascendis data threatens BioMarin's lead in achondroplasia - The Pharma Letter
Banzai International, Inc. (NASDAQ:BNZI) Sees Large Growth in Short Interest - Defense World
Ascendis Challenges BioMarin, But Market Response Seems Excessive (NASDAQ:BMRN) - Seeking Alpha
Ascendis trial data piles pressure on BioMarin - BioPharma Dive
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Pharmaceutical Technology
Bicara Therapeutics raises $362 million in Nasdaq debut - The Pharma Letter
BANPU Surges 6% Following NatGas Unit Launching IPO in NYSE - KAOHOON INTERNATIONAL
Bannix Acquisition Corp. Strives to Secure VisionWave Merger - TipRanks
U.S. Markets Finished Mixed Monday As Carvana Led, BioMarin Pharmaceutical Lagged - Barron's
Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term - Yahoo Finance
BioMarin off 17% as Ascendis data seen as threat to Voxzogo - Seeking Alpha
Ascendis rises on positive trial data for dwarfism therapy - XM
Banzai International Inc’s latest rating changes from various analysts - Knox Daily
(BNIX) On The My Stocks Page - Stock Traders Daily
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada
Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch
Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - MSN
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 - Investing.com India
TPG-backed Bicara Therapeutics raises $315 mln in US IPO - Reuters
Bannix Acquisition Corp. extends business combination deadline - Investing.com
Bannix Acquisition Corp. extends business combination deadline By Investing.com - Investing.com Australia
BNIX stock touches 52-week high at $11.2 amid market optimism - Investing.com Australia
Bannix Acquisition Corp Stock (BNIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):